Literature DB >> 29329759

Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.

Hayoung Choi1, Byung Woo Jhun1, Su-Young Kim1, Dae Hun Kim1, Hyun Lee1, Kyeongman Jeon1, O Jung Kwon1, Hee Jae Huh2, Chang-Seok Ki2, Nam Yong Lee2, Sung Jae Shin3, Charles L Daley4, Won-Jung Koh5.   

Abstract

Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15%-20% of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93% (13/14) following antibiotic therapy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug resistance; Macrolides; Mycobacterium abscessus; Nontuberculous mycobacteria; Treatment

Mesh：

Substances：

Year:  2017        PMID： 29329759     DOI： 10.1016/j.diagmicrobio.2017.12.008

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  7 in total

1.  GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

Authors:  Hee Jae Huh; Su-Young Kim; Hyang Jin Shim; Dae Hun Kim; In Young Yoo; On-Kyun Kang; Chang-Seok Ki; So Youn Shin; Byung Woo Jhun; Sung Jae Shin; Charles L Daley; Won-Jung Koh; Nam Yong Lee
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 2.  Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.

Authors:  Matt D Johansen; Jean-Louis Herrmann; Laurent Kremer
Journal:  Nat Rev Microbiol       Date:  2020-02-21       Impact factor: 60.633

3.  Mycobacterioses Induced by Mycobacterium abscessus: Case Studies Indicating the Importance of Molecular Analysis for the Identification of Antibiotic Resistance.

Authors:  Lenka Ryskova; Radka Bolehovska; Rudolf Kukla; Michal Svarc; Alzbeta Zavrelova; Hubert Vanicek; Ivo Pavlik; Pavel Bostik
Journal:  Antibiotics (Basel)       Date:  2022-06-28

4.  Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent.

Authors:  Mary A De Groote; Thale C Jarvis; Christina Wong; James Graham; Teresa Hoang; Casey L Young; Wendy Ribble; Joshua Day; Wei Li; Mary Jackson; Mercedes Gonzalez-Juarrero; Xicheng Sun; Urs A Ochsner
Journal:  Front Microbiol       Date:  2018-09-20       Impact factor: 5.640

5.  Genome reorganization during emergence of host-associated Mycobacterium abscessus.

Authors:  Lindsey L Bohr; Madison A Youngblom; Vegard Eldholm; Caitlin S Pepperell
Journal:  Microb Genom       Date:  2021-12

Review 6.  Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections.

Authors:  Davit Orujyan; William Narinyan; Subhapradha Rangarajan; Patrida Rangchaikul; Chaya Prasad; Beatrice Saviola; Vishwanath Venketaraman
Journal:  Vaccines (Basel)       Date:  2022-03-03

7.  Impact of Susceptibility to Injectable Antibiotics on the Treatment Outcomes of Mycobacterium abscessus Pulmonary Disease.

Authors:  Youngmok Park; Yea Eun Park; Byung Woo Jhun; Jimyung Park; Nakwon Kwak; Kyung-Wook Jo; Jae-Joon Yim; Tae Sun Shim; Young Ae Kang
Journal:  Open Forum Infect Dis       Date:  2021-05-12       Impact factor: 3.835
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.